CREBBP and Rubinstein-Taybi syndrome due to CREBBP mutations: This is a dosage-sensitive gene causing Rubinstein–Taybi syndrome type 1 (RSTS1) when deletions occur with the CREBBP gene [42], while there is no evidence for dosage pathogenicity when the gene is duplicated.